First clinical practice guideline for renal hypouricaemia: a rare disorder that aided the development of urate-lowering drugs for gout

Rheumatology (Oxford). 2021 Sep 1;60(9):3961-3963. doi: 10.1093/rheumatology/keab322.

Authors

Akiyoshi Nakayama¹, Hirotaka Matsuo¹, Abhishek Abhishek², Kimiyoshi Ichida³, Nariyoshi Shinomiya¹; members of Guideline Development Committee of Clinical Practice Guideline for Renal Hypouricaemia

Affiliations

¹ Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Japan.
² Academic Rheumatology, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.
³ Department of Pathophysiology, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

PMID: 34469572
DOI: 10.1093/rheumatology/keab322

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Drug Development*
Gout / drug therapy*
Gout Suppressants / pharmacology*
Humans
Practice Guidelines as Topic
Renal Tubular Transport, Inborn Errors / drug therapy*
Urinary Calculi / drug therapy*

Substances

Gout Suppressants

Supplementary concepts

Renal hypouricemia